Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
23 Oct 2020
Historique:
entrez: 30 10 2020
pubmed: 31 10 2020
medline: 11 11 2020
Statut: ppublish

Résumé

Spinal cord infarction (SCI) accounts for only 1% to 2% of all ischemic strokes and 5% to 8% of acute myelopathies. Magnetic resonance imaging (MRI) holds a role in ruling out non-ischemic etiologies, but the diagnostic accuracy of this procedure may be low in confirming the diagnosis, even when extensive cord lesions are present. Indeed, T2 changes on MRI can develop over hours to days, thus accounting for the low sensitivity in the hyperacute setting (ie, within 6 hours from symptom onset). For these reasons, SCI remains a clinical diagnosis. Despite extensive diagnostic work-up, up to 20% to 40% of SCI cases are classified as cryptogenic. Here, we describe a case of cryptogenic longitudinally extensive transverse myelopathy due to SCI, with negative MRI and diffusion-weighted imaging at 9 hours after symptom onset. A 51-year-old woman presented to our Emergency Department with acute severe abdominal pain, nausea, vomiting, sudden-onset of bilateral leg weakness with diffuse sensory loss, and paresthesias on the trunk and legs. On neurological examination, she showed severe paraparesis and a D6 sensory level. A 3T spinal cord MRI with gadolinium performed at 9 hours after symptom onset did not detect spinal cord alterations. Due to the persistence of a clinical picture suggestive of an acute myelopathy, a 3T MRI of the spine was repeated after 72 hours showing a hyperintense "pencil-like" signal mainly involving the grey matter from T1 to T6 on T2 sequence, mildly hypointense on T1 and with restricted diffusion. The patient was given salicylic acid (100 mg/d), prophylactic low-molecular-weight heparin, and began neuromotor rehabilitation. Two months later, a follow-up neurological examination revealed a severe spastic paraparesis, no evident sensory level, and poor sphincteric control with distended bladder. Regardless of its relatively low frequency in the general population, SCI should be suspected in every patient presenting with acute and progressive myelopathic symptoms, even in the absence of vascular risk factors. Thus, a clinical presentation consistent with a potential vascular syndrome involving the spinal cord overrides an initially negative MRI and should not delay timely and appropriate management.

Identifiants

pubmed: 33120840
doi: 10.1097/MD.0000000000022900
pii: 00005792-202010230-00116
pmc: PMC7581089
doi:

Substances chimiques

Anti-Infective Agents 0
Anticoagulants 0
Heparin, Low-Molecular-Weight 0
Salicylic Acid O414PZ4LPZ

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e22900

Références

Continuum (Minneap Minn). 2018 Apr;24(2, Spinal Cord Disorders):386-406
pubmed: 29613892
Nervenarzt. 2002 Oct;73(10):999-1003
pubmed: 12376890
Sci Rep. 2019 May 15;9(1):7435
pubmed: 31092838
Insights Imaging. 2018 Aug;9(4):549-557
pubmed: 29858818
J Neurol. 2004 Jul;251(7):818-24
pubmed: 15258783
J Clin Neurophysiol. 2007 Aug;24(4):336-43
pubmed: 17938602
Stroke. 1998 Jan;29(1):239-43
pubmed: 9445357
Neuroradiology. 2015 Mar;57(3):241-57
pubmed: 25398656
Spine J. 2014 Jun 1;14(6):e17-22
pubmed: 24252234
Pol J Radiol. 2015 Feb 23;80:93-106
pubmed: 25745524
Eur Radiol. 2004 Nov;14(11):2076-8
pubmed: 15022011
Continuum (Minneap Minn). 2018 Apr;24(2, Spinal Cord Disorders):407-426
pubmed: 29613893
Neuroradiology. 2006 Nov;48(11):795-801
pubmed: 16977443
Arch Neurol. 2006 Aug;63(8):1113-20
pubmed: 16908737
AJNR Am J Neuroradiol. 2015 May;36(5):825-30
pubmed: 25324492
J Clin Neurol. 2012 Sep;8(3):218-23
pubmed: 23091532
Mult Scler Relat Disord. 2016 Sep;9:62-7
pubmed: 27645347
J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2810-2821
pubmed: 30093205
Rinsho Shinkeigaku. 2016 May 31;56(5):352-5
pubmed: 27098903
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Neurology. 2012 Jan 10;78(2):114-21
pubmed: 22205760
J Clin Neurosci. 2015 Oct;22(10):1544-9
pubmed: 26154150

Auteurs

Gianluca Costamagna (G)

Department of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan.

Megi Meneri (M)

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit.

Elena Abati (E)

Department of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan.

Roberta Brusa (R)

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit.

Daniele Velardo (D)

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit.

Delia Gagliardi (D)

Department of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan.

Eleonora Mauri (E)

Department of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan.

Claudia Cinnante (C)

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neuroradiology Unit, Milan, Italy.

Nereo Bresolin (N)

Department of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan.
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit.

Giacomo Comi (G)

Department of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan.
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit.

Stefania Corti (S)

Department of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan.
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit.

Irene Faravelli (I)

Department of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH